Answers are grounded in this paper and cite their sources.
Patients with NVAMD enjoy heretofore unprecedented vision gains when managed with anti-VEGF therapy, and the limited body of evidence to date regarding long-term anti-VEGF treatment shows these vision gains can be maintained through 2 years. Further investigation is needed to explore the effects of long-term anti-VEGF therapy beyond 2 years.
No takes yet. Share an insight, caveat, or question.
Scott et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: